2016-2020 Emerging Opportunities in the Chlamydia Diagnostic Testing Market
The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health LabsFor each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Chlamydia tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 184 pages and 15 tables
- Commercial/Private Labs
- Physician Offices
- Public Health LabsFor each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Chlamydia tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 184 pages and 15 tables
I. INTRODUCTION
II. CHLAMYDIA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
Chlamydia Psittaci
Chlamydia Pneumoniae
Chlamydia Trachomatis
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
E. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
II. CHLAMYDIA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
Chlamydia Psittaci
Chlamydia Pneumoniae
Chlamydia Trachomatis
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
E. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
LIST OF TABLES
Major Companies Developing or Marketing Chlamydia Tests
France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Diagnostics Sales by Major Supplier
Germany Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Italy Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Diagnostics Sales by Major Supplier
Spain Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Spain Chlamydia Diagnostics Sales by Major Supplier
U.K. Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chlamydia Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Chlamydia Tests
France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Diagnostics Sales by Major Supplier
Germany Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Italy Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Diagnostics Sales by Major Supplier
Spain Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Spain Chlamydia Diagnostics Sales by Major Supplier
U.K. Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chlamydia Diagnostics Sales by Major Supplier
